ARTICLE | Company News
Ligand, Merck deal
January 18, 2010 8:00 AM UTC
Ligand received a $1 million milestone payment from Merck's Organon N.V. subsidiary under a 2007 deal to discover, develop and commercialize compounds for indications including neuroscience and immuno...